Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 21;11(8):e220276.
doi: 10.1530/EC-22-0276. Print 2022 Aug 1.

Resting energy expenditure in children at risk of hypothalamic dysfunction

Affiliations

Resting energy expenditure in children at risk of hypothalamic dysfunction

J Van Schaik et al. Endocr Connect. .

Abstract

Objective: Children with suprasellar brain damage are at risk of hypothalamic dysfunction (HD). HD may lead to decreased resting energy expenditure (REE). Decreased REE, however, is not present in all children with HD. Our aim was to assess which children suspect for HD have low REE, and its association with clinical severity of HD or radiological hypothalamic damage.

Patients and methods: A retrospective cohort study was performed. Measured REE (mREE) of children at risk of HD was compared to predicted REE (pREE). Low REE was defined as mREE <90% of predicted. The mREE/pREE quotient was associated to a clinical score for HD symptoms and to radiological hypothalamic damage.

Results: In total, 67 children at risk of HD (96% brain tumor diagnosis) with a mean BMI SDS of +2.3 ± 1.0 were included. Of these, 45 (67.2%) had low mREE. Children with severe HD had a significant lower mean mREE/pREE quotient compared to children with no, mild, or moderate HD. Mean mREE/pREE quotient of children with posterior hypothalamic damage was significantly lower compared to children with no or anterior damage. Tumor progression or tumor recurrence, severe clinical HD, and panhypopituitarism with diabetes insipidus (DI) were significant risk factors for reduced REE.

Conclusion: REE may be lowered in children with hypothalamic damage and is associated to the degree of clinical HD. REE is, however, not lowered in all children suspect for HD. For children with mild or moderate clinical HD symptoms, REE measurements may be useful to distinguish between those who may benefit from obesity treatment that increases REE from those who would be better helped using other obesity interventions.

Keywords: hypothalamic obesity; posterior hypothalamic damage; resting energy expenditure; suprasellar tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI imaging at diagnosis and 36 months after surgery in three cases of childhood craniopharyngioma with different grade of hypothalamic involvement/lesion. (A and B) Patient with craniopharyngioma confined to the intrasellar space (grade 0 = no hypothalamic involvement (A)/surgical lesion (B)). (C and D) Patient with craniopharyngioma involving the anterior hypothalamus (grade I: hypothalamic involvement (C)/surgical lesion of the anterior hypothalamic area (D)). (E and F) Patient with craniopharyngioma involving the anterior and posterior hypothalamus (grade II: hypothalamic involvement (E)/surgical lesion of the anterior and posterior hypothalamic area (F)). Arrows indicate mammillary bodies, defining the border between anterior and posterior involvement/lesion. Republished with permission of European Society of Endocrinology, from ‘Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up’, Müller et al., vol 165 iss 1, 2011 (20). Permission conveyed through Copyright Clearance Centre, Inc.
Figure 2
Figure 2
Clustered boxplot of resting energy expenditure quotients of children. Resting energy expenditure quotient: measured resting energy expenditure (mREE) divided by predicted resting energy expenditure (pREE) (calculated by Schofield equation).

References

    1. Roth CL.Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Frontiers in Endocrinology 20112 49. ( 10.3389/fendo.2011.00049) - DOI - PMC - PubMed
    1. Muller HL.Craniopharyngioma. Endocrine Reviews 201435513–543. ( 10.1210/er.2013-1115) - DOI - PubMed
    1. Iughetti L, Bruzzi P. Obesity and craniopharyngioma. Italian Journal of Pediatrics 201137 38. ( 10.1186/1824-7288-37-38) - DOI - PMC - PubMed
    1. Lustig RH.Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Frontiers in Endocrinology 20112 60. ( 10.3389/fendo.2011.00060) - DOI - PMC - PubMed
    1. van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM. Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocrine Reviews 201940193–235. ( 10.1210/er.2018-00017) - DOI - PubMed

LinkOut - more resources